Documents
Application Sponsors
NDA 020750 | SANOFI AVENTIS US | |
Marketing Status
Application Products
001 | SOLUTION;INHALATION | 0.5% | 0 | TILADE | NEDOCROMIL SODIUM |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 1997-10-01 | STANDARD |
Submissions Property Types
CDER Filings
SANOFI AVENTIS US
cder:Array
(
[0] => Array
(
[ApplNo] => 20750
[companyName] => SANOFI AVENTIS US
[docInserts] => ["",""]
[products] => [{"drugName":"TILADE","activeIngredients":"NEDOCROMIL SODIUM","strength":"0.5%","dosageForm":"SOLUTION;INHALATION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"TILADE","submission":"NEDOCROMIL SODIUM","actionType":"0.5%","submissionClassification":"SOLUTION;INHALATION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)